Clinical Trials Browser

Phase 2 × INDUSTRY × GSK 1363089 × Clear all

NCT00726323 2017-12-11

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Phase 2 Completed

74 enrolled 14 charts

Papillary renal cell carcinoma, sporadic, Carcinoma, Renal Cell

NCT00725764 2017-10-16

Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck

Phase 2 Completed

14 enrolled 14 charts

Head and Neck Neoplasms

NCT00725712 2017-08-24

Study of GSK1363089 in Metastatic Gastric Cancer

Phase 2 Completed

74 enrolled 22 charts

Gastrointestinal

Adenocarcinoma, Neoplasms, Stomach Neoplasms

NCT02034097 2014-05-19

A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Neoplasms